Crossmark

Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells

Crossref DOI link: https://doi.org/10.1186/s12943-018-0775-3

Published Online: 2018-02-19

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Shaocong

Fu, Liwu https://orcid.org/0000-0001-6795-2506
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81473233)

Science and Technology Program of Guangzhou (201504010038)

Science and Technology Program of Guangzhou (201604020079)

Science and Technology Program of Guangzhou (201601010008)
More Information

Article History

Received: 26 October 2017

Accepted: 1 February 2018

First Online: 19 February 2018

Consent for publication

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.